XML 47 R34.htm IDEA: XBRL DOCUMENT
v3.25.3

SHARE CAPITAL (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
SCHEDULE OF FAIR VALUE OF WARRANTS | SCHEDULE OF FAIR VALUE OF WARRANTS
|  | Private Placement Warrants |
Expected dividend yield |  |  | 0 | %
Share price |  | $ | 5.00 |
Expected share price volatility |  |  | 81.8 | %
Risk free interest rate |  |  | 2.57 | %
Expected life of warrant |  |  | 3 years |
SUMMARY OF COMMON SHARE PURCHASE WARRANT ACTIVITY | The following summarizes Common Share purchase warrant activity: SUMMARY OF COMMON SHARE PURCHASE WARRANT ACTIVITY
|  | Nine months ended |  |  | Year ended |
|  | September 30, 2025 |  |  | December 31, 2024 |
|  | Number Outstanding |  |  | Weighted Average Exercise Price $ |  |  | Number Outstanding |  |  | Weighted Average Exercise Price $ |
Outstanding, beginning of the year |  |  | 2,126,342 |  |  |  | 23.02 |  |  |  | 344,555 |  |  |  | 30.00 |
Issued |  |  | 7,313,726 |  |  |  | 9.57 |  |  |  | 1,814,070 |  |  |  | 22.00 |
Expired |  |  | (11,072 | ) |  |  | (35.00 | ) |  |  | (32,283 | ) |  |  | (41.00 | )
Outstanding, end of the period |  |  | 9,428,996 |  |  |  | 12.58 |  |  |  | 2,126,342 |  |  |  | 23.02 |
SCHEDULE OF DETAILS OF WARRANTS OUTSTANDING | At September 30, 2025, the Company had outstanding Common Share purchase warrants exercisable to acquire Common Shares as follows: SCHEDULE OF DETAILS OF WARRANTS OUTSTANDING
Warrants Outstanding |  |  | Warrants Exercisable |  |  | Expiry Date |  | Exercise Price $ |  |  | Intrinsic Value $ |
| 301,200 |  |  |  | 301,200 |  |  | June 28, 2026 |  |  | 28.75 |  |  |  | - |
| 1,012,981 |  |  |  | 1,012,981 |  |  | June 14, 2029 |  |  | 22.00 |  |  |  | - |
| 801,089 |  |  |  | 801,089 |  |  | June 21, 2029 |  |  | 22.00 |  |  |  | - |
| 3,833,334 |  |  |  | 3,833,334 |  |  | March 18, 2028 |  |  | 11.00 |  |  |  | - |
| 3,480,392 |  |  |  | 3,480,392 |  |  | March 18, 2028 |  |  | 8.00 |  |  |  | - |
| 9,428,996 |  |  |  | 9,428,996 |  |  |  |  |  |  |  |  |  | - |
SCHEDULE OF OPTION ACTIVITY | The following summarizes the Option activity: SCHEDULE OF OPTION ACTIVITY
|  | Nine months ended |  |  | Year ended |
|  | September 30, 2025 |  |  | December 31, 2024 |
|  | Number Outstanding |  |  | Weighted Average Exercise Price $ |  |  | Number Outstanding |  |  | Weighted Average Exercise Price $ |
Outstanding, beginning of the year |  |  | 779,343 |  |  |  | 25.60 |  |  |  | 674,401 |  |  |  | 27.80 |
Granted |  |  | 299,000 |  |  |  | 9.99 |  |  |  | 170,500 |  |  |  | 21.00 |
Exercised |  |  | (12,000 | ) |  |  | (9.00 | ) |  |  | (13,905 | ) |  |  | (17.20 | )
Expired/cancelled |  |  | (52,553 | ) |  |  | (19.53 | ) |  |  | (51,653 | ) |  |  | (40.20 | )
Outstanding, end of the period |  |  | 1,013,790 |  |  |  | 21.51 |  |  |  | 779,343 |  |  |  | 25.60 |
SCHEDULE OF FAIR VALUE OF STOCK OPTION GRANTED | SCHEDULE OF FAIR VALUE OF STOCK OPTION GRANTED
|  | Nine months ended |  |  | Year ended |
|  | September 30, 2025 |  |  | December 31, 2024 |
Expected dividend yield |  |  | 0 | % |  |  | 0 | %
Expected forfeiture rate |  |  | 0 | % |  |  | 0 | %
Expected share price volatility range |  |  | 76.3-78.6 | % |  |  | 74.2-79.8 | %
Weighted average expected share price volatility |  |  | 77.5 | % |  |  | 75.9 | %
Risk free interest rate |  |  | 2.54%-2.70 | % |  |  | 2.91%-3.23 | %
Expected life of Options |  |  | 2.5-3.5 years |  |  |  | 2.5-3.5 years |
SCHEDULE OF DETAILS OF OPTIONS OUTSTANDING | Details of Options outstanding as at September 30, 2025, are as follows: SCHEDULE OF DETAILS OF OPTIONS OUTSTANDING
Options Outstanding |  |  | Options Exercisable |  |  | Expiry Date |  | Exercise Price $ |  |  | Intrinsic Value $ |
| 160,736 |  |  |  | 160,736 |  |  | January 26, 2026 |  |  | 7.80 |  |  |  | - |
| 21,250 |  |  |  | 21,250 |  |  | February 25, 2026 |  |  | 32.00 |  |  |  | - |
| 55,335 |  |  |  | 55,335 |  |  | September 29, 2026 |  |  | 18.20 |  |  |  | - |
| 49,940 |  |  |  | 49,940 |  |  | October 25, 2026 |  |  | 40.00 |  |  |  | - |
| 97,499 |  |  |  | 97,499 |  |  | January 20, 2027 |  |  | 48.00 |  |  |  | - |
| 163,330 |  |  |  | 108,887 |  |  | August 8, 2028 |  |  | 35.00 |  |  |  | - |
| 151,700 |  |  |  | 101,133 |  |  | August 14, 2029 |  |  | 22.00 |  |  |  | - |
| 15,000 |  |  |  | 10,833 |  |  | December 4, 2029 |  |  | 9.80 |  |  |  | - |
| 287,500 |  |  |  | 143,750 |  |  | March 18, 2030 |  |  | 10.00 |  |  |  | - |
| 11,500 |  |  |  | 8,500 |  |  | April 24, 2030 |  |  | 9.80 |  |  |  | - |
| 1,013,790 |  |  |  | 757,863 |  |  |  |  |  |  |  |  |  | - |
SCHEDULE OF CONTINUITY OF RSU | The following is a continuity of the RSUs which are fixed and are not subject to vesting conditions other than service: SCHEDULE OF CONTINUITY OF RSU
|  | Nine months ended |  |  | Year ended |
|  | September 30, 2025 |  |  | December 31, 2024 |
|  | Number Outstanding |  |  | Weighted Average Grant-Date Fair Value Per Award $ |  |  | Number Outstanding |  |  | Weighted Average Grant-Date Fair Value Per Award $ |
Outstanding, beginning of the year |  |  | 50,000 |  |  |  | 12.00 |  |  |  | - |  |  |  | - |
Granted |  |  | 158,750 |  |  |  | 8.20 |  |  |  | 50,000 |  |  |  | 12.00 |
Vested / Settled |  |  | (4,166 | ) |  |  | (12.00 | ) |  |  | - |  |  |  | - |
Outstanding, end of the period |  |  | 204,584 |  |  |  | 9.04 |  |  |  | 50,000 |  |  |  | 12.00 |
SCHEDULE OF DSU GRANTED | SCHEDULE OF DSU GRANTED
|  | Number of Awards |  |  | Price(1) $ |  |  | Fair Value $ |
DSUs outstanding at December 31, 2023 |  |  | 36,548 |  |  |  | 24.20 |  |  |  | 884,481 |
Granted |  |  | 71,688 |  |  |  | 14.24 |  |  |  | 1,020,523 |
Fair value adjustment |  |  | - |  |  |  | - |  |  |  | (963,340 | )
DSUs outstanding at December 31, 2024 |  |  | 108,236 |  |  |  | 8.70 |  |  |  | 941,664 |
Redeemed |  |  | (19,335 | ) |  |  | 9.85 |  |  |  | (190,446 | )
Fair value adjustment |  |  | - |  |  |  | - |  |  |  | (73,792 | )
DSUs outstanding at September 30, 2025 |  |  | 88,901 |  |  |  | 12.60 |  |  |  | 677,426 |
Less: current portion |  |  | 39,915 |  |  |  | 12.60 |  |  |  | 339,959 |
Non-current portion |  |  | 48,986 |  |  |  | 12.60 |  |  |  | 337,467 |
Note:
(1) | For DSUs granted and outstanding, price represents the closing price of the Company’s Common Shares on the grant date and balance sheet date, respectively. For DSUs redeemed, price represents the volume weighted average price on the TSXV for the last five trading days immediately preceding the redemption date.
Monte Carlo Pricing Model [Member] |
SCHEDULE OF FAIR VALUE OF WARRANTS | SCHEDULE OF FAIR VALUE OF WARRANTS
|  | June 14, 2024 |  |  | June 21, 2024 |
Expected dividend yield |  |  | 0 | % |  |  | 0 | %
Share price |  | $ | 16.20 |  |  | $ | 16.80 |
Expected share price volatility |  |  | 83.17 | % |  |  | 83.71 | %
Risk free interest rate |  |  | 3.23 | % |  |  | 3.30 | %
Expected life of warrant |  |  | 5 years |  |  |  | 5 years |

X
- Definition Schedule Of Fair Value Warrants [Table Text Block] + References No definition available. + Details
Name: | NEXM_ScheduleOfFairValueWarrantsTableTextBlock
Namespace Prefix: | NEXM_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Warrants Or Rights Outstanding [Table Text Block] + References No definition available. + Details
Name: | NEXM_ScheduleOfWarrantsOrRightsOutstandingTableTextBlock
Namespace Prefix: | NEXM_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementScenarioAxis=NEXM_MonteCarloPricingModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |